Immunology
-
SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis
This article has 29 authors:Reviewed by ScreenIT
-
COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis
This article has 12 authors:Reviewed by ScreenIT
-
Longitudinal analysis of the humoral response to SARS-CoV-2 spike RBD in convalescent plasma donors
This article has 10 authors:Reviewed by ScreenIT
-
Exosome-Mediated mRNA Delivery For SARS-CoV-2 Vaccination
This article has 9 authors:Reviewed by ScreenIT
-
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
This article has 23 authors:Reviewed by ScreenIT
-
Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics
This article has 8 authors:Reviewed by ScreenIT
-
Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques
This article has 45 authors:Reviewed by ScreenIT
-
Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection
This article has 7 authors:Reviewed by ScreenIT
-
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
This article has 20 authors:Reviewed by ScreenIT
-
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates
This article has 64 authors:Reviewed by ScreenIT